Name: The US just authorized a 3rd coronavirus shot, adding a convenient, single-dose option to boost the rollout
Brand: businessinsider.com
SKU: businessinsider-com-793
Availability: OnlineOnly

critic

The US just authorized a 3rd coronavirus shot, adding a convenient, single-dose option to boost the rollout

preview

The word "Insider".Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.The US vaccination campaign received another jolt of good news, with US regulators on Saturday authorizing a third coronavirus vaccine for emergency use.&nbsp;This single-dose vaccine, developed by the healthcare giant Johnson &amp; Johnson, was found to be and safe and effective in a massive clinical trial. J&amp;J expects to quickly deliver nearly 4 million doses to the US, and they'll be made available to individuals for free.&nbsp;The authorization, which the FDA announced in a ,&nbsp;comes after an the shot. The FDA said J&amp;J's vaccine can be given to adults over age 18.With three authorized vaccines, the US is on the precipice of enjoying a surge in supply in the coming weeks. By according to drugmakers' projections, the to immunize 300 million people.&nbsp;J&amp;J's vaccine should bring some much-needed simplicity to a chaotic nationwide rollout. It's a single-dose immunization and can be kept stable for months at standard refrigerator temperatures. The other authorized vaccines in the US require two shots, several weeks apart.A 40,000-person trial found that J&amp;J's shot was safe and .The first two US-authorized vaccines&nbsp;&nbsp;at preventing symptomatic cases of COVID-19, though experts caution against comparing those figures directly.J&amp;J has emphasized its vaccine's ability to prevent the worst outcomes of COVID-19.Starting two weeks after receiving an injection in the study, 31 people were hospitalized with COVID-19: 29 had received the placebo shot and just two had gotten J&amp;J's vaccine. The study also tallied seven deaths from COVID-19 — all in the placebo group.Already, more than 47 million Americans have received at least one dose of a vaccine, .The accelerating immunization campaign is one reason to be optimistic about the state of the pandemic, doctors and scientists told Insider. They said they think that by summer, it'll be .On the other hand, coronavirus variants,&nbsp;, could bring a surge in cases. And we'll need to overcome some individuals' hesitancy to get a shot.Something is loading.Healthcare Explained:Get the latest from Business Insider Intelligence on how COVID-19 is affecting industries.NewsletterGet the latest healthcare news and analysis with our daily Insider Healthcare newsletter.Something is loading.It indicates an expandable section or menu, or sometimes previous / next navigation options.Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.

The word "Insider".Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.The US vaccination campaign received another jolt of good news, with US regulators on Saturday authorizing a third coronavirus vaccine for emergency use.&nbsp;This single-dose vaccine, developed by the healthcare giant Johnson &amp; Johnson, was found to be and safe and effective in a massive clinical trial. J&amp;J expects to quickly deliver nearly 4 million doses to the US, and they'll be made available to individuals for free.&nbsp;The authorization, which the FDA...

public

Andrew Dunn

What you want to know about business. A section of @thisisinsider. Follow us on Facebook, Instagram, and YouTube. Visit our homepage for the day's top stories.

businessinsider.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

The US just authorized a 3rd coronavirus shot, adding a convenient, single-dose option to boost the rollout

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS